Santhera Pharmaceuticals Holding AG (LON:0QN1)

LON:0QN1 Revenue

Santhera Pharmaceuticals Holding AG had revenue of 14.11M CHF in the half year ending June 30, 2024, with 125.82% growth. This brings the company's revenue in the last twelve months to 113.59M, up 2,100.48% year-over-year. In the year 2023, Santhera Pharmaceuticals Holding AG had annual revenue of 103.41M with 1,283.84% growth.

• Revenue (ttm): 113.59M CHF
• Revenue Growth: +2,100.48%
• P/S Ratio: 1.64
• Revenue / Employee: 2.54M CHF
• Employees: 45
• Market Cap: 164.03M GBP

Revenue Chart

* This company reports financials in CHF.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	103.41M	95.94M	1,283.84%
Dec 31, 2022	7.47M	9.07M	-568.53%
Dec 31, 2021	-1.60M	-16.60M	-110.63%
Dec 31, 2020	15.01M	-60.37M	-80.09%
Dec 31, 2019	75.38M	43.72M	138.10%